Works Cited


ClinicalTrials.gov. “Learn About Clinical Studies. NIH: U.S. National Library of Medicine.”

https://clinicaltrials.gov/ct2/about-studies/learn


Emery, P. (2010). New biologic for treating rheumatoid arthritis: Clinical trial experience with tocilizumab. International Journal of Clinical Rheumatology, 5(1), 17-24.

http://dx.doi.org.ezproxy.cul.columbia.edu/10.2217/ijr.09.66


Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, et al. Adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 2003;30:2563–71.


Mottonen, T., Hannonen, P., Leirisalo-Repo, M., Nissila, M., Kautiainen, H., Korpela, M., Friman, C., 1999. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 353 M.-H. Chou et al. Toxicology and Applied Pharmacology 334 (2017) 217–222 221 (9164), 1568–1573.


National Institutes of Health. “NIH Clinical Research Trials and You.” U.S. Department of Health & Human Services.

https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics


The National Patient-Centered Clinical Research Network. “Which Aspirin Dose is Best to Protect Patients with Heart Disease.” Patient-Centered Outcomes Research Institute.

https://www.pcori.org/sites/default/files/PCORI-Aspirin-Trial-Fact-Sheet.pdf


The National Patient-Centered Clinical Research Network. “PCORnet Bariatric Study.” Patient-Centered Outcomes Research Institute.

https://www.pcori.org/research-results/2015/pcornet-bariatric-study